🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of Tylenol, alleging the corporations concealed potential risks that the medication presented to children's cognitive development.

The court filing comes a month after President Donald Trump advocated an unverified association between taking acetaminophen - also known as acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is filing suit against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever suggested for expectant mothers, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "misled consumers by profiting off of suffering and promoting medication regardless of the potential hazards."

Kenvue says there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These manufacturers lied for decades, knowingly endangering millions to increase profits," Paxton, a Republican, stated.

The manufacturer stated officially that it was "very worried by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the welfare of US mothers and children."

On its website, Kenvue also said it had "consistently assessed the relevant science and there is lacking reliable evidence that shows a proven link between using paracetamol and autism."

Groups representing medical professionals and health professionals concur.

The leading OB-GYN organization has said acetaminophen - the key substance in acetaminophen - is among limited choices for women during pregnancy to address pain and fever, which can present major wellness concerns if ignored.

"In multiple decades of research on the consumption of acetaminophen in pregnancy, no reliable research has definitively established that the usage of paracetamol in any period of gestation results in neurological conditions in young ones," the association stated.

The lawsuit mentions recent announcements from the Trump administration in asserting the drug is potentially dangerous.

Recently, the former president caused concern from health experts when he told pregnant women to "resist strongly" not to use acetaminophen when sick.

The US Food and Drug Administration then published an announcement that physicians should contemplate reducing the consumption of Tylenol, while also declaring that "a proven link" between the drug and autism in young ones has remains unverified.

The Health Department head RFK Jr, who manages the FDA, had pledged in April to initiate "extensive scientific investigation" that would establish the cause of autism spectrum disorder in a limited time.

But experts warned that discovering a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a complex mix of inherited and environmental factors - would be difficult.

Autism is a type of permanent neurological difference and disability that influences how persons perceive and interact with the environment, and is identified using doctors' observations.

In his court filing, Paxton - a Trump ally who is seeking federal office - asserts the manufacturer and J&J "deliberately disregarded and sought to suppress the science" around acetaminophen and autism.

The case attempts to require the corporations "remove any marketing or advertising" that asserts Tylenol is safe for pregnant women.

The Texas lawsuit mirrors the complaints of a collection of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in recently.

A federal judge threw out the case, stating investigations from the plaintiffs' authorities was not conclusive.